APA (7th ed.) Citation

Wang, X., Li, S., Xiao, H., & Deng, X. (2020). Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer. Technology in cancer research & treatment, 19, 1533033820965574. https://doi.org/10.1177/1533033820965574

Chicago Style (17th ed.) Citation

Wang, Xiaojie, Shuang Li, Huiyu Xiao, and Xiaoqin Deng. "Serum LncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer." Technology in Cancer Research & Treatment 19 (2020): 1533033820965574. https://doi.org/10.1177/1533033820965574.

MLA (9th ed.) Citation

Wang, Xiaojie, et al. "Serum LncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer." Technology in Cancer Research & Treatment, vol. 19, 2020, p. 1533033820965574, https://doi.org/10.1177/1533033820965574.